XALKORI*
- Crizotinib - Xalkori-@- Anti-Cancer (Aug 2011)
Compositions:
Crizotinib- mg,
List of Related Indications:
Crizotinib- mg,
- Treat certain patients with late-stage(locally advanced or metastatic), non-small cell lung cancer (NSCLC) who express the abnormal anaplastic lymphoma kinase(ALK) gene
Strength | Rate | Packing Style |
---|---|---|
mg | 0.00 | unit |